Timely and Appropriate Treatment of Acute Stroke
- 22 April 1998
- journal article
- editorial
- Published by American Medical Association (AMA)
- Vol. 279 (16) , 1307-1309
- https://doi.org/10.1001/jama.279.16.1307
Abstract
Stroke is the third leading cause of death and the leading cause of serious, long-term disability in adults,1 accounting for an estimated $30 billion to $40 billion in direct and indirect costs annually.2 This staggering toll has prompted basic science and clinical researchers to transform the management of acute stroke from supportive therapy to an aggressive interventional strategy designed to actively restore cerebral perfusion and limit neurologic disability.3,4 The success of this strategy, however, depends on several key components, few of which are currently in place.Keywords
This publication has 15 references indexed in Scilit:
- Public Perception of Stroke Warning Signs and Knowledge of Potential Risk FactorsJAMA, 1998
- Rapid Response to Stroke Symptoms: The Delay in Accessing Stroke Healthcare (DASH) StudyAcademic Emergency Medicine, 1998
- PROACT: A Phase II Randomized Trial of Recombinant Pro-Urokinase by Direct Arterial Delivery in Acute Middle Cerebral Artery StrokeStroke, 1998
- Patients’ Awareness of Stroke Signs, Symptoms, and Risk FactorsStroke, 1997
- Knowledge of Risk Among Patients at Increased Risk for StrokeStroke, 1997
- Streptokinase for Acute Ischemic Stroke With Relationship to Time of AdministrationJAMA, 1996
- Lifetime Cost of Stroke in the United StatesStroke, 1996
- Guidelines for Thrombolytic Therapy for Acute Stroke: A Supplement to the Guidelines for the Management of Patients With Acute Ischemic StrokeCirculation, 1996
- Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)JAMA, 1995
- Factors associated with early presentation of acute stroke.Stroke, 1993